Interleukin-6 suppressive agent

Details Interleukin-6 suppressive agent Interleukin-6 suppressive agent

2007-09-13

2010-06-08

Lilling, Herbert J. (Department: 1657)

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

Oxidoreductases

C424S439000, C426S061000, C514S714000

Reexamination Certificate

active

07731955

ABSTRACT:
An interleukin-6 suppressive agent comprising lactoperoxidase as an active ingredient is used as a pharmaceutical preparation or the like for prevention and/or therapy of a disease caused by production of interleukin-6, such as thrombocytosis, myeloma, Castleman syndrome, rheumatoid arthritis, or influenza-virus infectious disease.

REFERENCES:
patent: 5561109 (1996-10-01), Mita et al.
patent: 7282202 (2007-10-01), Shiraki et al.
patent: 2002/0044989 (2002-04-01), Gaull
patent: 2002/0192296 (2002-12-01), Gaull et al.
patent: 2003/0012787 (2003-01-01), Ashkenazi et al.
patent: 2003/0027248 (2003-02-01), Bejanin et al.
patent: 0 791 359 (1997-08-01), None
patent: 1 002 542 (2000-05-01), None
patent: 61-83131 (1986-04-01), None
patent: 3-218318 (1991-09-01), None
patent: 05-009124 (1993-01-01), None
patent: 05-092927 (1993-04-01), None
patent: 05-124980 (1993-05-01), None
patent: 6-501453 (1994-02-01), None
patent: 2840795 (1998-10-01), None
patent: 2000-509367 (2000-07-01), None
patent: 2001-226289 (2001-08-01), None
patent: 2002-238554 (2002-08-01), None
patent: WO 91/06639 (1991-05-01), None
patent: WO 92/01466 (1992-02-01), None
Lefkowitz, et al. “Induction of Tumor Necrosis Factor and Cytotoxicity by Macrophages Exposed to Lactoperoxidase and Microperoxidase,”Life Sciences, vol. 47, No. 8, pp. 703-709, 1990.
Lefkowitz, et al. “Peroxidase-Induced Enhancement of Chemiluminescence by Murine Peritoneal Macrophages,”Life Sciences, vol. 43, No. 9, pp. 739-745, 1988.
Shin, et al. “Identification of Lactoperoxidase in Mature Human Milk,”Journal of Nutritional Biochemistry, vol. 11, pp. 94-102, Feb. 2000.
Wong, et al. “Immunomodulatory Activities of Whey Fractions in Efferent Prefemoral Lymph of Sheep,”Journal of Dairy Research, vol. 63, pp. 257-267, 1996.
Wong, et al. “Influence of Whey and Purified Whey Proteins on Neutrophil Functions in Sheep,”Journal of Dairy Research, vol. 64 pp. 281, 288, 1997.
Wong, et al. “Effects of Purified Bovine Whey Factors on Cellular Immune Functions in Ruminants,”Veterinary Immunology and Immunopathology, vol. 56, pp. 85-96, 1997.
Haversen, et al. “Human Lactoferrin and Peptides Derived from a Surface-Exposed Helical Region Reduce ExperimentalEscherichia coliUrinary Tract Infection in Mice,”Infection and Immunity, pp. 5816-5823, Oct. 2000.
Tenovuo, J., “Clinical Applications of Antimicrobial Host Proteins Lactoperoxidase, Lysozyme and Lactoferrin in Xerostomia: Efficacy and Safety,”Oral Diseases, vol. 8, No. 1, pp. 23-29, 2002.
van Hooijdonk, et al. “In vivo Antimicrobial and Antiviral Activity of Components in Bovine Milk and Colostrum Involved in Non-Specific Defence,”British Journal of Nutrition, vol. 84, Suppl. 1, pp. S127-S134, 2000.
Supplementary European Search Report dated May 23, 2008.

Affiliated with

Also associated with

Rating

Interleukin-6 suppressive agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Interleukin-6 suppressive agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interleukin-6 suppressive agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4198395